A Study of Cologuard™ in an Average Risk Population Assessing a Three Year Test Interval

NCT02419716 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2404

Last updated 2020-04-02

No results posted yet for this study

Summary

This is a prospective longitudinal study to assess the impact of repeat Cologuard testing at 3 years in average risk patients.

Conditions

Interventions

DEVICE

Cologuard

Prescription of Cologuard for at-home stool collection

Sponsors & Collaborators

  • Exact Sciences Corporation

    lead INDUSTRY

Principal Investigators

  • Thomas Imperiale, MD · Indiana University

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2020-03-16
Completion
2020-03-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02419716 on ClinicalTrials.gov